Switzerland based drug rebate management company raised $5.7m in Series A funding led by TX Ventures.
"The market for innovative and personalized treatments is expanding rapidly, but with that comes increasingly complex and costly pricing models."
Switzerland based drug rebate management company raised $5.7m in Series A funding led by TX Ventures.
"The market for innovative and personalized treatments is expanding rapidly, but with that comes increasingly complex and costly pricing models."
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net